Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients

Ning Zhang, Yuhuan Gong, Fanping Meng, Yuhai Bi, Penghui Yang, Fusheng Wang
doi: https://doi.org/10.1101/2020.03.28.20043059
Ning Zhang
1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), Chinese Academy of Sciences, Beijing 100101, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuhuan Gong
2Institutes of Physical Science and Information Technology, Anhui University, Hefei, 230601, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fanping Meng
3The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, P. R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuhai Bi
1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), Chinese Academy of Sciences, Beijing 100101, China
4Shenzhen Key Laboratory of Pathogen and Immunity, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious Diseases, State Key Discipline of Infectious Disease, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen Third People’s Hospital, Shenzhen 518112, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Beeyh@im.ac.cn ypenghuiamms@hotmail.com fswang302@163.com
Penghui Yang
3The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, P. R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Beeyh@im.ac.cn ypenghuiamms@hotmail.com fswang302@163.com
Fusheng Wang
3The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing 100039, P. R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Beeyh@im.ac.cn ypenghuiamms@hotmail.com fswang302@163.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Diagnosis is the key point for confirmation and treatment of COVID-19. we focused on comparative analysis of virus dynamics between the upper respiratory and feces specimens in the COVID-19 patients. A total of 66 upper respiratory swabs, 51 feces, 56 urine and 56 plasma samples were sequentially collected from 23 patients in a designated hospital. The plasma and urine samples were all negative, except for urine samples from two severe cases at the latest available detection point. Conversely, virus was shed in respiratory swabs and feces samples during the diseased period. Ten of 12 (83.3%) cases were positive for feces samples, while 14 of 21 (66.7%) were positive for respiratory samples. In addition, the median duration of virus shedding was 10.0 days (IQR 8.0 to 17.0) in the upper respiratory swabs, but was 22.0 days (IQR 15.5 to 23.5) for the feces. Notably, at 26 days after discharge, case 3 (a 45-year-old) was detected positive again in the feces samples, but appears to be healthy and negative for respiratory swabs. These results indicated that beside respiratory samples, intestinal samples (e.g. feces) should be recommended for diagnosis of COVID-19, especially before a patient discharge and for monitoring the relapse of discharged patients.

An acute viral pneumonia (COVID-19), caused by the novel coronavirus HCoV-19, was first identified during December 2019 in China(1). HCoV-19 was found to be highly transmissible in humans(2) and is now a pandemic, with transmission into over 140 countries, causing over 150,000 infections and 6,000 deaths as of March 15, 2020 (3).

Diagnosis is critical for confirmation and treatment of COVID-19. Viral RNA detection for the respiratory samples is currently the primary criteria for diagnosis of COVID-19. Two studies on virus loads in clinical samples have been recently reported, in which viral loads in nasal and throat swabs and sputum specimens peaked at three to seven days after illness onset (d.a.o.) and virtually disappeared before 15 d.a.o.(4, 5). Another study showed that the median duration of virus shedding in throat swabs was 20 d.a.o. in survivors and was detectable until death in non-survivors(6). Additionally, live viruses have been isolated in the feces and urine samples of COVID-19 patients. However, the viral dynamics in these two types of specimens have not yet been elucidated, as well as comparative studies on virus shedding in the upper respiratory, intestinal and urinary tracts.

From January 20 to February 23, 2020, a total of 23 patients were treated in a designated hospital in Beijing (11 were imported, 12 were secondary cases; two family clusters; 12 men, 11 women; median age was 48.0 years (IQR 40.0 to 62.0); two with severe disease, the others were mild-to-moderate, all patients recovered except for one due to an unrelated bacterial infection) (Table S1 in the Supplementary appendix). Upper respiratory (nasal-throat mixed) swabs (n= 66), feces (n= 51), urine (n= 56), and plasma (n= 56) samples were collected for viral RNA detection by real-time RT-PCR (rRT-PCR). The study was approved by the Ethics Committees of Chinese Academy of Sciences (SQIMCAS20). Informed consent was obtained from all subjects for being included in the study, and all patient data were anonymized before study inclusion.

The plasma and urine samples were all negative, except for urine samples from two severe cases at the latest available detection point (16 or 21 d.a.o). Conversely, virus was shed in respiratory swabs and feces samples during the diseased period (Figure 1A). Ten of 12 cases (83.3%) were positive for feces samples, while 14 of 21 cases (66.7%) were positive for respiratory samples. In addition, all samples from one severe patient were negative until 21 d.a.o., when feces samples were positive. The median duration of virus shedding was 10.0 days (IQR 8.0 to 17.0) in nasal-throat mixed swabs, but was 22.0 days (IQR 15.5 to 23.5) for the feces (Figure 1 B). The viral titers of nasal-throat swabs peaked at six to nine d.a.o. and at 14-18 d.a.o for fecal samples, and the highest virus titers at the peak was significantly higher for feces (105.8 copies/ml, mean 5623 copies/ml) than of respiratory samples (106.3 copies/ml, mean 2535 copies/ml) (Figure 1A). Notably, at 26 days after discharge, case 3 was detected positive again in feces samples, but appears to be healthy and negative for respiratory swabs. These results indicated that beside respiratory samples, intestinal samples (e.g. feces) should be recommended for diagnosis of COVID-19, especially for monitoring the relapse of discharged patients.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Virus dynamics in nasopharyngeal and fecal specimens of COVID-19 cases

The nasal-throat mixed swabs and fecal samples of all 23 cases were detected by rRT-PCR targeting ORF1ab, N and S genes (Mabsky Biotech Co., Ltd., CONFORMITE EUROPEENNE NO.), the Ct values of ORF1ab gene were shown in (A). Sequential nasal-throat mixed swabs, feces, urine, and plasma samples were collected in 11 cases and used for virus detection. The Ct values of nasal-throat mixed swabs (solid line) and feces (dotted line) specimens were shown in (B). Two cases with severe diseases, identified according to the guideline of HCoV-19 infection from the National Health Commission of the People’s Republic of China, were colored in red. The other eight cases with mild-to-moderate symptoms were in black. Ct values were inversely related to viral RNA copy number, with Ct values of 37.6, 32.64, 29.22, and 25.77 corresponding to 1×103, 1×104, 1×105, and 1×106 copies per mL. Negative samples were denoted with a Ct value of 43, which was the limit of detection.

We declare no competing interests. This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) (Grant No. XDB29010102). Y.B. is supported by the NSFC Outstanding Young Scholars (Grant No. 31822055), and Youth Innovation Promotion Association of CAS (Grant No. 2017122). We declare no competing interests.

Data Availability

We promise all data referred to in the manuscript is availability.

References

  1. 1.↵
    Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–3.
    OpenUrlCrossRefPubMed
  3. 3.↵
    World Health Organization (2020). Coronavirus disease (COVID-19) outbreak. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
  4. 4.↵
    Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020.
  5. 5.↵
    Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020.
  6. 6.↵
    Zhou F. YT, Du R., Fan G., Liu Y., Liu Z.*, Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020.
Back to top
PreviousNext
Posted March 30, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients
Ning Zhang, Yuhuan Gong, Fanping Meng, Yuhai Bi, Penghui Yang, Fusheng Wang
medRxiv 2020.03.28.20043059; doi: https://doi.org/10.1101/2020.03.28.20043059
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients
Ning Zhang, Yuhuan Gong, Fanping Meng, Yuhai Bi, Penghui Yang, Fusheng Wang
medRxiv 2020.03.28.20043059; doi: https://doi.org/10.1101/2020.03.28.20043059

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (166)
  • Anesthesia (49)
  • Cardiovascular Medicine (447)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
  • Epidemiology (5199)
  • Forensic Medicine (3)
  • Gastroenterology (193)
  • Genetic and Genomic Medicine (746)
  • Geriatric Medicine (76)
  • Health Economics (211)
  • Health Informatics (689)
  • Health Policy (350)
  • Health Systems and Quality Improvement (221)
  • Hematology (98)
  • HIV/AIDS (161)
  • Infectious Diseases (except HIV/AIDS) (5793)
  • Intensive Care and Critical Care Medicine (355)
  • Medical Education (101)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (754)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (230)
  • Oncology (473)
  • Ophthalmology (149)
  • Orthopedics (37)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (138)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (135)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (851)
  • Public and Global Health (1985)
  • Radiology and Imaging (342)
  • Rehabilitation Medicine and Physical Therapy (154)
  • Respiratory Medicine (282)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (74)
  • Surgery (107)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)